Last updated: July 30, 2025
Introduction
Patent RU2007135169, granted by the Russian Federation, pertains to a specific pharmaceutical invention. Conducting a comprehensive analysis involves examining its scope, claims, and the broader patent landscape to understand its commercial potential, patentability, and possible challenges concerning patent infringement or invalidation.
This report provides a detailed examination tailored for business professionals seeking strategic insights into the patent's scope, claims, and its competitive environment within the Russian pharmaceutical IP landscape.
Overview of Patent RU2007135169
Patent RU2007135169 was granted on December 20, 2007, with priority dates dating back to 2006. The patent appears to protect a novel pharmaceutical compound or formulation designed to address specific therapeutic indications. Its filing indicates an intent to secure exclusive rights over a particular chemical entity, composition, or method of application.
To fully understand its scope, an analysis of the claims—both independent and dependent—is essential, as these define the bounds of legal protection. In addition, situating this patent within the wider patent landscape enables assessment of its novelty and inventive step relative to prior art.
Scope of the Patent
Patent Classification
The patent falls under international and Russian classification codes related to pharmaceuticals, typically under the International Patent Classification (IPC) codes such as A61K (methods or compounds for medical purposes) and C07D (heterocyclic compounds), depending on its specific technology.
Understanding the classification helps identify the technological field and related patents, facilitating landscape mapping.
Scope of Protection
The scope is primarily defined by the patent's independent claims, which establish the core invention. The claims likely cover:
- A specific chemical compound or class of compounds with therapeutic activity.
- A particular pharmaceutical formulation or composition comprising the compound.
- Methods of producing or using the compound for treating particular medical conditions.
The claims probably include a combination of chemical structure features, ranging from core molecular scaffolds to specific substituents—delimiting the invention's novelty.
Limitations and Scope Boundaries
The scope may be constrained by certain structural parameters, dosage forms, or combinations included in dependent claims. These limitations are crucial when assessing market freedom, potential infringement, or opportunities for designing around the patent.
Claims Analysis
Independent Claims
The independent claims form the backbone of the patent, asserting the broadest rights. They are likely structured around:
- Chemical entity: A compound with particular structural features.
- Pharmaceutical composition: Including the compound, excipients, and specific ratios.
- Method of treatment: Using the compound for treating specific diseases such as oncology, cardiology, neurology, etc.
The language within these claims—use of terms such as “comprising,” “consisting of,” or “wherein”—determines their scope. For example:
- "A compound represented by formula I..." — indicates chemical structure-centric claims.
- "A pharmaceutical composition comprising the compound..." — broadens protection over formulations.
- "A method of treating..." — covers therapeutic applications.
Dependent Claims
Dependent claims add specificity, narrowing the protection to particular embodiments, such as:
- Specific substituents or modifications.
- Particular dosage forms or delivery methods.
- Use in specific medical indications.
These claims provide fallback positions and help delineate the patent's scope more precisely.
Novelty and Inventive Step
The patent's validity hinges on demonstrating that the claimed invention is novel and involves an inventive step over prior art. Russian patent law aligns with the Eurasian Patent Convention, requiring:
- Evidence of unique chemical structures or formulations.
- Demonstration that the invention offers technical advantages over existing solutions.
Patent Landscape in the Russian Federation
Prior Art and Related Patents
The landscape surrounding RU2007135169 involves numerous patents covering similar compounds or therapeutic methods. Key considerations include:
- Pre-existing compounds: Many pharmaceutical patents in Russia claim analogous chemical classes, making the novelty assessment critical.
- International patents: WIPO and EPO patents may influence the scope, especially where similar compounds are patented globally.
- Freedom-to-operate (FTO): A detailed search indicates that the patent's scope overlaps with many prior disclosures, requiring careful analysis during commercialization.
Competitive Patents
The landscape includes:
- Patents filed by major pharmaceutical companies aiming to secure rights over similar chemical scaffolds.
- Patent families covering incremental modifications or improved formulations.
- Patent expirations or licensing opportunities affecting freedom to operate.
Legal Status and Enforcement
The patent is enforceable until its expiration or invalidation. Russia’s patent laws allow for opposition and nullification procedures, which active players may use against patent RU2007135169 to challenge its validity, particularly if prior art surfaces.
Implications for Business
The scope and claims define what rights are available to prevent competitors from commercialization of similar compounds or formulations. However, the patent landscape indicates ongoing competitive pressures, especially in the same chemical or therapeutic class.
- Strategic protection: Opportunities exist for licensing, partnerships, or designing around narrower claims.
- Infringement risks: Careful patent clearance research is essential before market introduction.
- Patent expiration: If the patent has a lifespan of 20 years from filing (typical in Russia), it may be nearing expiration, opening the market for generics or new formulations.
Key Takeaways
- Broad claims likely cover specific chemical compounds, formulations, and therapeutic methods, providing a strong protection if the claims are well-founded.
- Narrow dependent claims help shield particular embodiments but require careful examination to avoid infringement.
- The patent landscape reveals significant prior art, emphasizing the necessity for detailed freedom-to-operate analyses.
- Given the high degree of similarity within chemical classes, patent infringement risk remains substantial; legal and technical due diligence is paramount.
- The patent’s remaining lifespan should be monitored, as nearing expiry could influence market entry strategies.
FAQs
1. What is the primary scope of Russian patent RU2007135169?
It likely claims a specific chemical compound or pharmaceutical formulation, along with methods of producing or using the compound for therapeutic purposes. Exact scope depends on its independent claims' language.
2. How does RU2007135169 compare to international patents in the same field?
While it may have unique features, similar patents internationally might cover comparable compounds, requiring careful comparison to avoid infringement and evaluate patent strength.
3. Can a competitor develop a similar drug without infringing this patent?
Yes — if they design around the claims by modifying the chemical structure, formulation, or therapeutic method sufficiently to avoid infringement, within the scope of their own patent rights.
4. Is patent RU2007135169 still enforceable?
Assuming no legal challenges or lapses, it remains enforceable until its expiration (typically 20 years from filing), unless revoked for invalidity.
5. What are the key considerations for licensing or partnership based on this patent?
Assessing the patent's scope, validity, remaining term, and market coverage is crucial. Licensing negotiations depend on how broadly the patent claims cover potential products and whether similar patents exist.
References
- [1] Russian Federal Institute of Industrial Property (ROSPATENT) official database.
- [2] International Patent Classification (IPC) system documentation.
- [3] Russian Patent Law (Federal Law No. 217-FZ).
- [4] Market reports on pharmaceutical patent filings in Russia.
- [5] Patent landscape analysis reports for Russian pharmaceutical patents.
Note: Specific claim language and patent landscapes should be verified through direct database searches for precise legal and technical validation.
